Alcon to Acquire LENSAR in a $430 Million Deal
Alcon Inc. (ALC) entered a merger agreement on March 24, 2025, to acquire LENSAR, Inc. (LNSR) in a deal valued at about $430 million. Deal
Read More
March 24, 2025
Alcon Inc. (ALC) entered a merger agreement on March 24, 2025, to acquire LENSAR, Inc. (LNSR) in a deal valued at about $430 million. Deal
Read More
Dun & Bradstreet Holdings, Inc. (DNB) entered a merger agreement on March 24, 2025, to be acquired by private equity firm Clearlake Capital Group, L.P.
Read More
Fiber-cement maker James Hardie Industries (JHX) entered a merger agreement on March 23, 2025, to acquire artificial decking maker The AZEK Company Inc. (AZEK) in
Read More
Paratek Pharmaceuticals entered a merger agreement on March 19, 2025, to acquire OptiNose, Inc. (OPTN) for $330 million. Deal Structure: Under the agreement, Paratek will
Read More
The Doctors Company, a medical malpractice insurer, entered a merger agreement on March 19, 2025, to take ProAssurance Corporation (PRA) private in a $1.3 billion
Read More
Recycled metal products maker Radius Recycling, Inc. (RDUS) entered a merger agreement on March 13, 2025, to be acquired by Toyota Tsusho America for $1.34
Read More
2seventy bio, Inc. (TSVT) entered a merger agreement on March 10, 2025, to be taken private by Bristol-Myers Squibb Company (BMY) in an all-cash deal
Read More
Canada’s oil producer Whitecap Resources Inc. (SPGYF) entered a merger agreement on March 10, 2025, to merge with peer Veren Inc. (VRN) in an all-stock
Read More
Rocket Companies, Inc. (RKT) entered a merger agreement on March 10, 2025, to acquire Redfin Corporation (RDFN) in an all-stock deal valued at $1.75 billion. Details
Read More
India’s Sun Pharmaceutical Industries Limited entered a merger agreement on March 9, 2025, to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (CKPT)
Read More
Walgreens Boots Alliance, Inc. (WBA) entered a merger agreement on March 6, 2025, to be taken private by Sycamore Partners in a deal valued at
Read More
Jazz Pharmaceuticals plc (JAZZ) entered a merger agreement on March 5, 2025, to acquire Chimerix, Inc. (CMRX) through an all-cash tender offer valued at $935
Read More